Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Argus Health
AstraZeneca
Mallinckrodt
McKinsey
Cipla
Dow
Express Scripts
Merck
Harvard Business School

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,149,579

« Back to Dashboard

Which drugs does patent 9,149,579 protect, and when does it expire?


Patent 9,149,579 protects AUVI-Q and is included in one NDA.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 9,149,579

Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a movable member and a valve coupled to the movable member. The movable member is configured to be disposed within a housing of a medical device and has a first end portion and second end portion. A portion of the first end portion is configured to define a portion of a boundary of a gas chamber. The first end portion defines an opening configured to be in fluid communication between the gas chamber and an area outside the gas chamber. The second end portion is configured to be coupled to a needle configured to deliver a medicament into a body. The valve is configured to selectively allow fluid communication between the gas chamber and the area outside the gas chamber through the opening defined by the first end portion of the movable member.
Inventor(s): Edwards; Evan Thomas (Gordonsville, VA), Edwards; Eric Shawn (Moseley, VA), Licata; Mark J. (Doswell, VA)
Assignee: kaleo, Inc. (Richmond, VA)
Application Number:13/748,728
Patent Claim Types:
see list of patent claims
Dosage form; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► Subscribe METHOD OF TREATING ALLERGIC REACTION VIA INJECTION
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► Subscribe METHOD OF TREATING ALLERGIC REACTION VIA INJECTION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,149,579

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,926,594Devices, systems and methods for medicament delivery► Subscribe
7,731,690Devices, systems and methods for medicament delivery► Subscribe
9,056,170Devices, systems and methods for medicament delivery► Subscribe
8,313,466Devices, systems and methods for medicament delivery► Subscribe
8,226,610Medical injector with compliance tracking and monitoring► Subscribe
8,172,082Devices, systems and methods for medicament delivery► Subscribe
8,361,029Devices, systems and methods for medicament delivery► Subscribe
7,416,540Devices systems and methods for medicament delivery► Subscribe
9,555,191Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
7,947,017Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,149,579

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2011519712► Subscribe
Japan5653345► Subscribe
Japan2010510000► Subscribe
European Patent Office2285360► Subscribe
European Patent Office2355858► Subscribe
Spain2396745► Subscribe
Spain2577517► Subscribe
United Kingdom0708523► Subscribe
United Kingdom2434548► Subscribe
United Kingdom0713202► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Julphar
US Army
Deloitte
McKinsey
Accenture
Moodys
Daiichi Sankyo
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot